Bayer AG (Germany) Performance
| BAYN Stock | EUR 19.42 0.06 0.31% |
The firm shows a Beta (market volatility) of -0.0995, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bayer AG are expected to decrease at a much lower rate. During the bear market, Bayer AG is likely to outperform the market. At this point, Bayer AG NA has a negative expected return of -0.52%. Please make sure to confirm Bayer AG's kurtosis, daily balance of power, and the relationship between the skewness and accumulation distribution , to decide if Bayer AG NA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bayer AG NA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 4.2 B | |
| Total Cashflows From Investing Activities | 855 M |
Bayer |
Bayer AG Relative Risk vs. Return Landscape
If you would invest 2,810 in Bayer AG NA on September 1, 2024 and sell it today you would lose (868.00) from holding Bayer AG NA or give up 30.89% of portfolio value over 90 days. Bayer AG NA is producing return of less than zero assuming 2.5808% volatility of returns over the 90 days investment horizon. Simply put, 22% of all stocks have less volatile historical return distribution than Bayer AG, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bayer AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayer AG's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bayer AG NA, and traders can use it to determine the average amount a Bayer AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.203
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BAYN |
Estimated Market Risk
| 2.58 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bayer AG is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayer AG by adding Bayer AG to a well-diversified portfolio.
Bayer AG Fundamentals Growth
Bayer Stock prices reflect investors' perceptions of the future prospects and financial health of Bayer AG, and Bayer AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 83.74 B | |||
| Shares Outstanding | 982.42 M | |||
| Price To Earning | 11.34 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 44.08 B | |||
| EBITDA | 6.45 B | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 8.34 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.17 % | |||
| Book Value Per Share | 42.01 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 4.78 X | |||
| Total Asset | 120.24 B | |||
| Current Asset | 25.17 B | |||
| Current Liabilities | 16.68 B | |||
About Bayer AG Performance
By analyzing Bayer AG's fundamental ratios, stakeholders can gain valuable insights into Bayer AG's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bayer AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayer AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany.Things to note about Bayer AG NA performance evaluation
Checking the ongoing alerts about Bayer AG for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bayer AG NA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bayer AG NA generated a negative expected return over the last 90 days |
- Analyzing Bayer AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer AG's stock is overvalued or undervalued compared to its peers.
- Examining Bayer AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayer AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayer AG's stock. These opinions can provide insight into Bayer AG's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bayer Stock analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |